Last month, I openly declared that a Trump Presidency was going to kick off Tesla’s New Bullish Cycle Folks who listened and bought in when I said to are currently crushing it. As a matter of fact, all the trades we’ve opened ever since I made that public declaration have ALL been winners. And it’s simply because this Tesla indicator just flipped green on the stock…

Nicholas Corcoran net worth and biography

Nicholas Corcoran Biography and Net Worth

Insider of TransMedics Group

Nick Corcoran joins TransMedics with over 20 years of experience in global supply chain and commercial operations. Prior to joining TransMedics, Mr. Corcoran served multiple roles of increasing responsibility at Stryker Corporation. Most recently, Mr. Corcoran served as Vice President of Division Operations for Stryker Joint Replacement, managing the division’s entire supply chain, including internal manufacturing sites and external supply partners. Earlier in his career at Stryker, Mr. Corcoran served as Vice President of Division and Commercial Operations for the Spine Division, Senior Director of Division Operations, and Director of Global Sourcing. He also held a variety of Supply Chain and Operations roles at Waters Corporation and Intel Corporation. Mr. Corcoran holds a bachelor’s degree in Finance and Economics from South East Technological University and a Master’s of Business in Supply Chain Management from The Smurfit School of Business, University College Dublin.

What is Nicholas Corcoran's net worth?: The estimated net worth of Nicholas Corcoran is at least $1.60 million as of August 27th, 2024. Mr. Corcoran owns 21,105 shares of TransMedics Group stock worth more than $1,604,824 as of November 23rd. This net worth estimate does not reflect any other investments that Mr. Corcoran may own. Additionally, Mr. Corcoran receives a salary of $812,070.00 as Insider at TransMedics Group. Learn More about Nicholas Corcoran's net worth.
How old is Nicholas Corcoran?: Mr. Corcoran is currently 41 years old. There are 4 older executives and no younger executives at TransMedics Group. The oldest executive at TransMedics Group is Ms. Miriam C. Provost Ph.D., Vice President of Global Regulatory Affairs, who is 63 years old. Learn More on Nicholas Corcoran's age.
What is Nicholas Corcoran's salary?: As the Insider of TransMedics Group, Inc., Mr. Corcoran earns $812,070.00 per year. There are 3 executives that earn more than Mr. Corcoran. The highest earning executive at TransMedics Group is Dr. Waleed H. Hassanein M.D., Founder, President, CEO & Director, who commands a salary of $1,820,000.00 per year. Learn More on Nicholas Corcoran's salary.
How do I contact Nicholas Corcoran?: The corporate mailing address for Mr. Corcoran and other TransMedics Group executives is 200 MINUTEMAN ROAD SUITE 302, ANDOVER MA, 01810. TransMedics Group can also be reached via phone at (978) 552-0900 and via email at [email protected]. Learn More on Nicholas Corcoran's contact information.
Has Nicholas Corcoran been buying or selling shares of TransMedics Group?: Nicholas Corcoran has not been actively trading shares of TransMedics Group within the last three months. Most recently, Nicholas Corcoran sold 10,000 shares of the business's stock in a transaction on Tuesday, August 27th. The shares were sold at an average price of $176.02, for a transaction totalling $1,760,200.00. Following the completion of the sale, the insider now directly owns 21,105 shares of the company's stock, valued at $3,714,902.10. Learn More on Nicholas Corcoran's trading history.
Who are TransMedics Group's active insiders?: TransMedics Group's insider roster includes John Carey (VP), Nicholas Corcoran (Insider), Laura Damme (VP), Stephen Gordon (CFO), Waleed Hassanein (CEO), Edwin Kania, Jr. (Director), Tamer Khayal (Insider), Miriam Provost (VP), and Anil Ranganath (Insider). Learn More on TransMedics Group's active insiders.
Are insiders buying or selling shares of TransMedics Group?: In the last year, insiders at the sold shares 45 times. They sold a total of 477,855 shares worth more than $53,882,883.25. The most recent insider tranaction occured on November, 5th when Director Edward M Basile sold 6,750 shares worth more than $563,962.50. Insiders at TransMedics Group own 7.0% of the company. Learn More about insider trades at TransMedics Group.
Information on this page was last updated on 11/5/2024.

Nicholas Corcoran Insider Trading History at TransMedics Group

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
8/27/2024	Sell	10,000	$176.02	$1,760,200.00	21,105
5/6/2024	Sell	3,222	$129.91	$418,570.02	21,105

Nicholas Corcoran Buying and Selling Activity at TransMedics Group

TransMedics Group Company Overview

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its OCS includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage and for ex vivo reanimation, functional monitoring, and beating-heart preservation of donation-after-circulatory-death hearts; and OCS Liver for the preservation of DBD and DCD of donor livers. The company also developed national OCS program, a turnkey solution for outsourced organ retrieval; and provides OCS organ management and logistics services, including aviation and ground transportation, and other coordination activity. The company was founded in 1998 and is headquartered in Andover, Massachusetts.

Today's Range

Now: $76.04

$72.68

$76.87

50 Day Range

MA: $120.68

$77.20

$165.98

2 Week Range

Now: $76.04

$67.77

$177.37

Volume

2,599,470 shs

Average Volume

990,945 shs

Market Capitalization

$2.55 billion

P/E Ratio

80.89

Dividend Yield

N/A

Beta

2.08

I hate to say I told you so

From WealthPress | Ad

Follow this link right away.

Nicholas Corcoran Biography and Net Worth

What is Nicholas Corcoran's net worth?

How old is Nicholas Corcoran?

What is Nicholas Corcoran's salary?

How do I contact Nicholas Corcoran?

Has Nicholas Corcoran been buying or selling shares of TransMedics Group?

Who are TransMedics Group's active insiders?

Are insiders buying or selling shares of TransMedics Group?